Comparison

UNC8153 (TFA) European Partner

Item no. HY-157251-5mg
Manufacturer MedChem Express
CASRN 2929304-61-8
Amount 5 mg
Quantity options 1 ea 10 mg 5 mg
Specific against other
Purity 99.91
Citations [1]Ronan P Hanley, et al. Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2. J Am Chem Soc. 2023 Apr 12;145(14):8176-8188.
Smiles O=C(C(F)(F)F)O.O=C(C1=CC=C(CN(C2CC2)C(C3=CC=C4NC(COC4=C3)=O)=O)C=C1)NC5=CC=C(C(NCCCCCCN)=O)C=C5
Available
Product Description
UNC8153 TFA is a potent and selective nuclear receptor-binding SET domain-containing 2 (NSD2)-targeted degrader with a Kd of 24 nM. UNC8153 TFA reduces the cellular levels of both NSD2 protein and the H3K36me2 chromatin mark. UNC8153 TFA contains a simple warhead that confers proteasome-dependent degradation of NSD2[1].
StorageTemperature
-20°C (Powder, sealed storage, away from moisture)
Shipping
Blue Ice
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
697.70
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
DMSO : 100 mg/mL (ultrasonic)|H2O : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Target
Histone Methyltransferase
Manufacturers Target
Histone Methyltransferase
Manufacturers Pathway
Epigenetics
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close